FPH announces its results for the 2023 financial year

Fisher & Paykel Healthcare Corporation Limited announced its results for the 2023 financial year, with total operating revenue of $1.58 billion, down 6% or 9% in constant currency from the 2022 financial year.

Net profit after tax was $250.3 million, a 34% decline from the 2022 financial year, or a 39% decline in constant currency.

The company saw strong growth in masks and accessories revenue, with OSA masks revenue up 28% or 24% in constant currency.

The board of directors approved a final dividend of 23.0 cents per share, bringing the total dividend for the 2023 financial year to 40.5 cents per share, an increase of 3% over the 2022 financial year.

The company invested $174.3 million into research and development and continued to add people to the global sales team.

For the 2024 financial year, the company expects operating revenue of approximately $1.70 billion and a gross margin improvement of approximately 200 basis points in constant currency.